All cells need to sense and respond to their environment—to know when to activate genes, build proteins and carry out their basic functions. One of the most well-studied cellular responses is how they ...

In a phase 1 study, anti-CD7 chimeric antigen receptor (CAR) T cells induced complete remission in children and adults with relapsed or refractory T-cell acute lymphoblastic leukemia (ALL), with 82% ...

Acute lymphoblastic leukemia (ALL) can lead to reduced production of healthy blood cells, increasing the risk of anemia, thrombocytopenia, and infections. Blood clots and central nervous system ...

Cellular health plays a crucial role in your overall well-being. On average, the human body has between 30-40 trillion cells of various types and with various functions. The healthier your cells are, ...

CD7 is an attractive target for chimeric antigen receptor (CAR) T-cell therapy in relapsed or refractory T-cell acute lymphoblastic leukemia (ALL). Supportive results of first-in-human studies of base ...

All cells need to sense and respond to their environment, to know when to activate genes, build proteins, and carry out their basic functions. One of the most well-studied cellular responses is how ...